Literature DB >> 9495707

High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later.

R S Malek1, D M Barrett, R S Kuntzman.   

Abstract

OBJECTIVES: To study the feasibility and immediate postoperative outcome of vaporization prostatectomy by high-power potassium-titanyl-phosphate (KTP/532) laser in 10 men with bladder outlet obstruction due to benign prostatic hyperplasia (BPH) and to evaluate their clinical and voiding outcome 24 hours postoperatively.
METHODS: The KTP/532 laser at 60 W was produced by a prototype Laserscope generator and delivered through a side-deflecting fiber with a 22F continuous-flow cystoscope. Sterile water was used for irrigation. The prostatic lobes were readily vaporized to within capsular fibers. The mean lasing time was 29 +/- 8 minutes, during which a mean of 104.6 +/- 30 kJ of energy was delivered.
RESULTS: The prostate volumes ranged from 22 to 60 mL (mean 38.4 +/- 9.7). None of the 10 patients had any significant blood loss or any fluid absorption. Foley catheters were removed in less than 24 hours postoperatively. All patients were satisfied with their voiding outcome. The mean peak urine flow rate increased from 8 +/- 1.3 mL/s preoperatively to 19.4 +/- 8.4 mL/s (142%, P = 0.003266) 24 hours postoperatively. Postvoid residual volumes remained essentially unchanged from their preoperative levels, as expected (P = 0.767423). One patient had urgency, but none had dysuria, hematuria, or incontinence or required recatheterization. Three patients have returned for 3-month follow-up; all 3 patients have had excellent results and are very satisfied with the outcome.
CONCLUSIONS: Our very early and limited experience indicates that high-power KTP/532 laser vaporization prostatectomy is feasible and appears to be safe and effective for quickly relieving bladder outlet obstruction due to BPH. Larger randomized clinical trials to compare this technique with standard transurethral resection of the prostate and more follow-up data are needed to determine its long-term efficacy and durability.

Entities:  

Mesh:

Year:  1998        PMID: 9495707     DOI: 10.1016/s0090-4295(97)00613-4

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  40 in total

1.  Recent advances in the surgical treatment of benign prostatic hyperplasia.

Authors:  Bernardo Rocco; Giancarlo Albo; Rafael Coelho Ferreira; Matteo Spinelli; Gabriele Cozzi; Paolo Dell'orto; Vipul Patel; Francesco Rocco
Journal:  Ther Adv Urol       Date:  2011-12

2.  Laser ablation of the prostate: a safe effective treatment of obstructive benign prostatic disease.

Authors:  Edward Woods
Journal:  Can Urol Assoc J       Date:  2010-10       Impact factor: 1.862

3.  Greenlight high-performance system (HPS) 120-W laser vaporization versus transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a meta-analysis of the published results of randomized controlled trials.

Authors:  Yan Zhou; Boxin Xue; Nadeem Ahmed Mohammad; Dong Chen; Xiaofei Sun; Jinhui Yang; Guangcheng Dai
Journal:  Lasers Med Sci       Date:  2016-02-11       Impact factor: 3.161

4.  Safety and efficacy of the potassium-titanyl-phosphate laser and photoselective vaporization of the prostate for benign prostatic hyperplasia.

Authors:  Claus G Roehrborn
Journal:  Rev Urol       Date:  2006

Review 5.  The evolution of photoselective vaporization prostatectomy (PVP): advancing the surgical treatment of benign prostatic hyperplasia.

Authors:  Richard Lee; Ricardo R Gonzalez; Alexis E Te
Journal:  World J Urol       Date:  2006-05-13       Impact factor: 4.226

6.  [Diode laser. Ex vivo studies on vaporization and coagulation characteristics].

Authors:  M Seitz; A Ackermann; C Gratzke; B Schlenker; R Ruszat; A Bachmann; C Stief; O Reich; R Sroka
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

7.  Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement.

Authors:  Michael Seitz; Robin Ruszat; Thomas Bayer; Derya Tilki; Alexander Bachmann; Christian Stief; Ronald Sroka; Oliver Reich
Journal:  Lasers Med Sci       Date:  2008-08-07       Impact factor: 3.161

8.  New alternatives for laser vaporization of the prostate: experimental evaluation of a 980-, 1,318- and 1,470-nm diode laser device.

Authors:  Felix Wezel; Gunnar Wendt-Nordahl; Nina Huck; Thorsten Bach; Christel Weiss; Maurice Stephan Michel; Axel Häcker
Journal:  World J Urol       Date:  2009-12-25       Impact factor: 4.226

9.  Vaporization of the prostate with 150-w thulium laser: complications with 6-month follow-up.

Authors:  César Vargas; Alejandro García-Larrosa; Santiago Capdevila; Ainhoa Laborda
Journal:  J Endourol       Date:  2014-03-31       Impact factor: 2.942

10.  The efficacy and safety of simultaneous transurethral GreenLight photoselective vaporization of bladder tumor and prostate in patients with bladder tumor and lower urinary tract symptoms.

Authors:  Zhaoyi Li; Ruipeng Hou; Jian Li
Journal:  Int Urol Nephrol       Date:  2013-10-05       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.